MaitakeGold 404® Boosts Immunity

BRATTLEBORO, Vt.The TradeWorks Group announced new findings on the safety and effectiveness of MaitakeGold 404®, a proprietary extract of Maitake mushroom (Grifola frondosa). A three-year, U.S. government-funded, multi-phase, human clinical study of MaitakeGold 404s immune-enhancing properties was initiated at Memorial Sloan-Kettering Hospital. In a phase I/II trial, 34 subjects took MaitakeGold 404 at varying doses for three weeks. Researchers discovered balanced immune support (immunomodulation) occurred in subjects at all dosage levels, including low doses with no adverse effects or toxicity. After three weeks, T-cell activity increased, as did levels of immune-enhancing cytokines, and anti-inflammatory cytokines (IL-10). The study demonstrated that MaitakeGold 404 is highly bioavailable while being safe to use when taken orally on a daily basis. In addition, the proprietary mushroom extract is effective in supporting immunity while limiting inflammation that can be associated with a healthy immune response.